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Abstract
Streptomyces are saprophytic bacteria ubiquitous in soil and well-known as producers
of two-thirds of clinically used antibiotics. Antibiotic production and in some cases
morphological differentiation is regulated by population density dependent signaling.
Among the signaling molecules that have been identified, γ-butyrolactones (GBLs) form
the major class. GBLs are small diffusible molecules which function at nanomolar con-
centrations and three major structural types are known. Due to limited quantities of
GBLs produced, the traditional approach of isolation and structure determination fol-
lowed by the study of functional roles is challenging. The development of two new recep-
tor based reporter systems for A-factor and Virginiae Butanolide type GBLs is reported
here. Together with a previously developed reporter for SCB type GBLs, these reporters
can be utilized for screening environmental samples and pure compounds for signaling
activity. They are useful for studying the specificity of various GBL signal-receptor
systems among Streptomyces and to identify potential new signaling molecules. The
reporters also serve as valuable tools in the study of GBL signal based communication
between Streptomyces and other species and contribute towards a broader understand-
ing of the role of signaling in Streptomyces ecology and evolution. Even though the
development of fully functional reporters could not be completed, this study provides
valuable insight into the many issues associated with developing Streptomyces based
reporter systems. Modifications to the reporter system that may address these issues
are discussed. Further, results from preliminary studies conducted for developing high
throughput methods for screening signaling activity among Streptomyces isolates are
also reported.
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Chapter 1
Background and Significance
Bacteria use chemical signaling molecules to mediate their interactions with the envi-
ronment as well as with members of their own or different species. A chemical signaling
molecule is defined as a metabolite from one cell which induces a change in other cells
that is not due to the metabolism of the signaling molecule [56]. It has been shown that
bacterial characteristics such as virulence, antibiotic production, biofilm formation, sym-
biosis, competence, conjugation and motility are community behaviors facilitated by a
type of signaling known as population density-dependent signaling or Quorum Sensing
[8]. Population density-dependent signaling is presumed to have evolved due to the ef-
fectiveness of a community based response to an external disturbance as opposed to the
response of a single cell [62]. The concentration of signaling molecules present gives an
indirect measure of the cell density of the producer species and as a result, at high cell
densities certain beneficial behaviors can be cooperatively turned on more effectively
by the signal receivers (see Figure 1.1 for a schematic representation). The study of
microbial signaling is an emerging field and the structures of the signaling molecules
identified in the known interactions are found to be varied, Acyl Homoserine Lactone
(AHL) type molecules are commonly found among Gram-negative bacteria, modified
oligopeptides among Gram-positive bacteria and autoinducer-2 (AI-2) signaling system
found in many Gram-positive and Gram-negative bacteria. [62].
Research on signaling systems indicates that signaling occurs mostly between closely
related species and that signal-receiver interactions are highly specific, presumably to
prevent non-signal producers from taking undue advantage of the outcome of signaling
1
2Figure 1.1: Population density dependent signaling. At low cell density, signaling molecules secreted
by cells are present in the environment at low concentrations. A critical concentration of the signaling
molecule is reached at high cell densities and this causes certain genes to be ”turned on”, resulting in
the concerted production of the gene product.
[50]. Despite this, myriad types of interactions have also been observed with examples
found in literature for eavesdropping, in which a signal produced by one species is used
as a cue by another and cross-talk between two species due to the overlap between signals
of the producing and receiving species [12] [38] [30]. Recent research has also suggested
that signaling molecules mediate inter-kingdom interactions between soil bacteria and
plants [24] [35].
Ecological implications of these signaling interactions and how species interactions
have driven the evolution of signaling is a growing research topic. Various aspects of
signaling in terms of the frequency of signaling, the specificity of signaling molecules and
receptors, the identity of various types of signaling molecules and the functions of these
interactions in the environment need to be further investigated. Another important
reason to pursue the study of signaling molecules is the potential it offers to understand
the regulation of important microbial behaviors such as antibiotic production and vir-
ulence. Developing robust and sensitive tools for signal molecule detection is integral
to the discovery of new signaling molecules and to identify additional roles of signaling
molecules. These detection systems when used in large-scale screening studies can pro-
vide valuable information about the signal producers and receivers that will shed light
on the dynamics of signal-mediated communication in various ecosystems. For example,
the reporters may be used to screen a wide variety of samples of any origin - microbial,
plant or animal and detect the presence of specific signaling compounds. They may also
3be utilized to test isolates from various geographically separated microbial communities
to learn patterns of signaling among various proximate species, as well as factors that
influence signaling and its effect on microbial behaviors.
This chapter introduces γ-butyrolactone (GBL) signaling systems found among
Streptomyces. The mechanism and role of GBL signaling, the structure of signaling
molecules and the methods used for detecting GBLs are discussed. The challenges asso-
ciated with the discovery of GBLs, the motivation for developing reporter systems and
applications of the reporters are also explained. A reporter system developed by Hsiao
et al. for detecting SCB-type GBLs found in Streptomyces coelicolor and their findings
using this reporter is discussed in detail. The development of similar reporter systems
for A-factor and Virginiae butanolide (VB) signaling compounds found in Streptomyces
griseus and Streptomyces virginiae, respectively, is presented in this thesis. A brief
literature review of A-factor and VB signaling systems is also presented. In Chapter
2, methods used for developing the new reporters and conducting the bioassays are
described. Chapter 3 examines the results of this study and Chapter 4 presents the
conclusions and future directions.
1.1 Signaling in Streptomyces
Streptomyces is a genus of approximately 550 species of aerobic, gram positive, non-
motile, high G+C bacteria. They are found ubiquitously in bulk soil and marine sedi-
ments, and are associated with plants as endophytes and members of rhizosphere com-
munities. Streptomyces undergo a complex developmental life cycle and the morpholog-
ical differentiation stages are often closely associated with the production of secondary
metabolites [19]. Close symbiotic associations of Streptomyces with plants, fungi and
bacteria have been observed and may have evolved as a direct result of their ability to
produce these secondary metabolites [53]. Antibiotic synthesis, turned on in the sta-
tionary growth phase, is generally believed to be a defense mechanism to prevent motile,
competing species from exploiting their food resources [9].
About two-thirds of all clinically used natural antibiotics are produced by Strepto-
myces [63]. Some examples of clinically important Streptomyces antibiotics are strep-
tomycin, vancomycin, chloramphenicol and avermectin which are used for targeting
4diseases ranging from typhoid and tuberculosis to cancer [9]. The antibiotic synthesis
genes in Streptomyces are mostly arranged in clusters under the control of pathway
specific regulatory genes [7]. Genomic studies of several Streptomyces spp. have shown
the presence of many such clusters of as yet unknown activity [57]. This suggests their
potential to produce many more antibiotics, making them an economically important
genus. GBLs (γ-butyrolactones) coordinate the production of antibiotics and in some
cases sporulation in Streptomyces. They act as pleiotropic regulators or higher level reg-
ulators of the pathway specific regulatory genes and are consequently studied for their
involvement in the regulation of antibiotic and other secondary metabolite synthesis.
GBLs are small, hydrophobic molecules synthesized in nanomolar quantities which
can easily diffuse through membranes into the extracellular environment. The first GBL
discovered from Streptomyces was A-factor, which induces streptomycin production and
sporulation in Streptomyces griseus [32]. Subsequently, additional GBL structures were
reported from other actinomycetes that also play a role in antibiotic production and
morphological differentiation [10]. To date, structures of 14 different GBLs from seven
species of Streptomyces have been identified (Figure 1.2). GBL compounds are divided
into three major structural types depending on the bond at the C-6 position: 6-keto type
( e.g. A-factor), (6R)-hydroxy type ( e.g. SCB1-3, IM-2 ) and (6S)- hydroxy type (e.g.
virginiae butanolides A - E) [19]. Bacteria that recognize GBL signals are exquisitely
sensitive to their cognate structures. For example, nanomolar concentrations of A-factor
and SCB1 induce the production of actinorhodin in S.griseus and undecylpordigiosin
in S.coelicolor respectively [16] [58]. The extremely small quantities in which GBLs
are produced, their sensitivity and closely related structures indicate the highly specific
nature of this signaling process.
A number of other signaling molecules which regulate both morphogenesis and an-
tibiotic production have also been isolated from Streptomyces. Methylenomycin Furans
(MMFs), siderophores and peptides like SapB are a few examples [64]. More recently,
butenolides such as avenolide from S.avermitilis and SRB1 and SRB2 from S.rochei were
identified as inducers of antibiotic synthesis in these species [3] [34]. These butenolides
are structurally slightly different from GBLs, but specifically induce antibiotic produc-
tion in the producing species. GBLs still remain the largest group of signaling molecules
discovered in Streptomyces and are generally assumed to be the more common form of
5Figure 1.2: The structure, type, and producing species of the 14 GBLs identified so far. The
functional group at the C-6 position (shown in green) differentiates the structures into 3 distinct types:
A-factor type, IM-2 type and VB type. The common structural elements are given in blue and the
length and branching variations in side chains are shown in red.
signaling in Streptomyces [65]. Extensive research has been done on understanding how
GBL signaling operates and many of the pathways and genes involved have been iden-
tified. The mechanism of action of non-GBL signaling molecules and their regulation
are only beginning to be understood.
1.2 GBL Signaling Mechanism
In Streptomyces, genes involved in antibiotic synthesis occur as clusters which are held
under transcriptional control of pathway specific regulatory genes [7]. GBL signaling
molecules induce antibiotic production by binding specifically to the receptor protein
6which is the transcriptional repressor for antibiotic synthesis. The binding causes confor-
mational changes in the repressor protein so that it can no longer bind to the promoter
DNA of the antibiotic cluster [57]. The relief of repression by the signaling molecule
thus results in antibiotic synthesis. This mechanism is illustrated in Figure 1.3. Most
GBLs negatively regulate their own synthesis as well so that at any point in time the
concentration of GBLs in an environment is a reflection of the population density of the
producing species [57]. Only when a critical concentration is reached does the signaling
cascade become activated.
Figure 1.3: Mechanism of action of GBLs. Here the Streptomyces antibiotic biosynthetic genes (abg)
are depicted as a cluster which is under the regulation of a single Streptomyces Antibiotic Regulatory
Protein (SARP). In the absence of GBL, expression of SARP is repressed by the GBL receptor protein.
In the presence of GBL, repression is relieved by the binding of GBL to the GBL receptor and the SARP
activates the abg genes which culminate in the production of antibiotic. Image from Mast et al. [40]
1.3 Search for GBL-like Molecules That Can Bind to GBL
Receptors
Homology searches of the known GBL receptor and synthase genes show that a number
of Streptomyces species carry homologs of these genes, indicating the presence of puta-
tive GBL signaling systems [57]. However, the extremely small quantities in which GBLs
are produced make their isolation and detection challenging [57]. Hundreds of liters of
7bacterial culture must be grown and purified through High Performance Liquid Chro-
matography (HPLC) to obtain microgram quantities of the GBL. The limited quantity
of molecules available makes the downstream structure elucidation by techniques like
Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS) challenging. Hence,
a number of alternative approaches have been designed for the study of GBLs.
The most widely used assay for the detection of GBLs is via the induction of antibi-
otic production since this is the most common end result of the signal-receptor binding
cascade. Antibiotic production can be monitored visually (in the case of colored antibi-
otics), spectrophotometrically or through bacterial growth inhibition assays [58]. Even
though this method is simple and convenient, there are several disadvantages. Although
the signal-receptor binding triggers antibiotic synthesis, a large number of other factors
are involved in the ultimate expression of antibiotic thereby affecting the validity of
the method. Also, parameters such as inoculum concentration, duration of cultivation,
media, growing conditions etc. affect the reproducibility of these assays [23]. Therefore,
methods which can directly detect signal-receptor binding are considered to be more
sensitive and reliable [23]. In addition to detecting GBLs, direct GBL receptor protein-
based methods can be utilized for studying the binding of cognate and non-cognate
molecules to GBL receptors, thereby establishing the sensitivity and specificity of the
receptor proteins and discover the interaction patterns among Streptomyces species.
In this category, several new approaches both in vivo and in vitro have been estab-
lished such as His-tagged GBL receptors coupled with mass spectrometry (MS), cell-free
translation with GFP expression coupled to the GBL receptor binding gene, the GBL
receptor protein affinity capture matrix coupled with tandem mass spectrometry and
kanamycin resistance expression coupled to the GBL receptor binding gene [69] [23] [70]
[25]. Although these methods measure direct binding of GBLs to the receptors, there
are some significant drawbacks. The mass spectrometric methods give direct structural
information but are challenging to perform and can only be used to detect the most
abundant analog of GBL present in the sample, which in most cases also has the lowest
binding affinity to the corresponding receptor [69]. The cell-free translation method de-
veloped in E.coli was used to measure the binding of non-cognate signals C6-Homoserine
lactone and VB-C to the SCB receptor protein [70]. The SCB receptor protein based
8kanamycin resistance bioassay developed by Hsiao et al. is also a similar, simpler sys-
tem and successfully showed the binding of 18 non-cognate synthetic GBLs and signals
from extracts of two Streptomyces isolates to the SCB receptor protein [23]. Because
of the promising results obtained using this system, which is described in detail in the
following section, this project was undertaken to develop similar detection systems for
the other two structural classes of GBL molecules: A-factor type and VB type.
1.4 Kanamycin Resistance Bioassay Using the SCB Re-
ceptor Protein Based Reporter
Hsiao et al. modeled a reporter system based on the actual GBL signaling cascade. A
promoterless kanamycin resistance gene is fused to the promoter of the gene repressed
by the GBL receptor so that the expression of the kanamycin resistance gene is repressed
in the absence of the GBL. In the presence of the GBL, the binding of the GBL to the
receptor relieves the repression and causes kanamycin resistance gene to be expressed.
Thus, a reporter strain which carries these genes will be able to grow in the presence of
kanamycin only when a signaling molecule that can bind to the receptor is present.
A host strain which cannot produce or detect signals is also required to prevent the
interference from natural signaling molecules and receptors. Hsiao et al. developed a
host strain, LW16, by disrupting scbA gene which is the key gene involved in Strepto-
myces coelicolor Butyrolactone (SCB) biosynthesis and scbR gene which encodes the
SCB receptor protein in S.coelicolor [23]. Since Streptomyces do not stably maintain
recombinant plasmids, an integrating vector pIJ82, was designed by Hsaio et al. for the
chromosomal integration. The plasmid pIJ82 is a Streptomyces phage-derived vector
containing the int gene which encodes an integrase enzyme enabling it to integrate into
S.coelicolor genome based on specific attachment sites. The recombinant vector pTE134
(see Figure 1.4) was then constructed from the plasmid pIJ82 by inserting scbR gene
and a promoterless kanamycin resistance gene, neo, fused to the cpkO promoter. The
cpkO promoter is one of the native DNA targets of ScbR in S.coelicolor and its binding
regulates the expression of a Type I polyketide antibiotic cluster of unknown function.
The plasmid pTE134 was introduced into host strain LW16 to create the SCB reporter
(LW16::pTE134). The SCB reporter can be used in the kanamycin resistance bioassay
9Figure 1.4: Map of pTE134, the plasmid developed for the SCB reporter kanamycin resistance
bioassay. The plasmid pTE134 carries the scbR with its own promoter region, scbRp and a cpkO
promoter, cpkOp, coupled with a promoterless kanamycin resistant gene, neo. It also has the hygromycin
resistance gene, hyg, as the selectable marker for the plasmid and the int gene (phiC31 integrase) for
chromosomal integration of plasmid based on attP attachment site (phiC31 attP site). The plasmid
pTE134 was introduced into S.coelicolor LW16 to create the SCB reporter. (Image taken from Hsiao et
al. [23])
to detect SCBs and structurally related GBLs, presumably of the SCB type. In the ab-
sence of a suitable signaling molecule, ScbR will repress the neo gene and the reporter
will be susceptible to kanamycin. The ability of the reporter to grow in the presence of
kanamycin will indicate the presence of signaling molecules capable of binding to ScbR
(Figure 1.5).
1.5 The Scope of the Kanamycin Resistance Bioassay Us-
ing the SCB Reporter
The advantages of the kanamycin resistance bioassay are that it is simple, efficient and
provides fast results. It gives clear positive results with the size of the halo corre-
sponding (although not linearly) to the amount of signaling molecule spotted. Also,
the principle on which it works is direct and follows the natural signaling mechanism of
GBLs. Signals which weakly bind to the receptor protein and may not give detectable
antibiotic production in antibiotic assays can give positive results in this assay. Hsiao
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Figure 1.5: Kanamycin resistance bioassay results when tested with pure synthetic SCB1 (left) and
the extract from wild type S.coelicolor, M145 (right). The SCB reporter spores were plated on the agar
medium containing kanamycin and the compound/extract spotted in the center. Following incubation,
the SCB reporter spores were observed to grow around the area in which the signaling molecules diffused.
(Image from Hsiao et al. [23])
et al. successfully used the SCB reporter as a screening tool for assessing the binding
of native and non-native synthetic GBLs to ScbR. They found that SCB3, one of the
three SCBs isolated from S.coelicolor, was the most effective in binding to ScbR. Only
0.006 µg of SCB3 was required to obtain a positive result in the kanamycin resistance
bioassay. In contrast, A-factor which is not known to be produced by S.coelicolor, only
induced a positive response at 0.625 µg indicating a significantly weaker binding affinity.
The results of Hsiao et al. from screening other synthetic GBLs with the SCB reporter
are shown in Table 1.1. Hsiao et al. also tested the reporter with synthetic analogs of
the three types of GBLs, varying in their chain lengths and branching. They found that
the branching at the C-6 position is the preferred ligand to ScbR [23]. The kanamycin
resistance bioassay with the SCB reporter demonstrated an improved ability to detect
non-cognate signals that bind to ScbR compared to the indirect antibiotic induction
assays. The lower detection limit makes it a promising tool for studying the binding of
non-cognate ligands to GBL receptors [23].
The SCB reporter also provides a good model system for developing new reporters
for other GBL receptors. A-factor type and VB type GBLs form the remaining two
known GBL structural types and the genes involved in their regulation are known.
This makes the development of reporters for these systems based on the SCB reporter
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Table 1.1: Minimum concentrations of synthetic racemic GBLs that activated the SCB reporter
(Data from Hsiao et al.[23]). The minus sign indicates that no halo was observed on the plate at the
concentrations tested. The highest concentration tested was 62.5 µg for VB-C and 31.25 µg for IM-2.
model comparatively simple. Since the S.coelicolor host strain, LW16, used in the
SCB reporter does not produce A-factor or VB signals, it can be utilized as the host
strain for new reporters as well. Employing similar detection systems also ensures
the comparability of results obtained with different reporters. The SCB reporter was
successful in showing that non-cognate signals can bind to the SCB receptor protein.
Developing new reporters based on the other GBLs will help elucidate more aspects of
GBL signaling, including how effectively a single type of signaling molecule may bind
to multiple receptors and vice versa. The SCB reporter together with new reporters for
A-factor and VB systems will be ideal tools for examining the communication patterns
among Streptomyces sp. through signals encompassing all three GBL types and provide
more comprehensive understanding of its role in interspecies, intraspecies and inter-
kingdom interactions.
1.6 A-factor System
A-factor, also called autoregulatory factor (2-isocapryloyl-3R-hydroxymethyl-γ- buty-
rolactone), from Streptomyces griseus was the first GBL signaling molecule to be dis-
covered from Streptomyces. Most GBLs regulate only secondary metabolite production
but A-factor induces sporulation, streptomycin biosynthesis and production of a yellow
pigment, grixazone, in S.griseus and hence it can be considered as a representative of
GBL-type regulators which control both morphological and physiological differentiation
12
[32] [18] [47].
In liquid culture, A-factor is produced in a growth dependent manner with con-
centrations reaching 25 ng/ml at the end of exponential phase [16]. After this critical
concentration is reached, the amount of A-factor rapidly decreases due to a cease in its
production coupled with the instability of A-factor in water and other media [2] [18].
Horinouchi et al. has given an excellent illustration of the time scale of A-factor pro-
duction in relation to growth and secondary metabolite production in S.griseus (see
Figure 1.6) [18]. Timing is important for the inducing function of A-factor since com-
mitment to sporulation and streptomycin biosynthesis are determined early in the de-
velopment cycle, usually 10-12 hours after inoculation [5] [45]. This period is called the
decision phase or A-factor sensitive period since after this point addition of A-factor to
the media will not affect morphological or physiological differentiation [2] [45] .
The complete biosynthetic pathway of A-factor has been elucidated and the gene
afsA which encodes the key enzyme in the the biosynthetic pathway has been identified
and characterized [26] [20] [21]. AfsA, a 301 amino acid protein, catalyzes the acyl
transfer between a C10 β-ketoacyl bound acyl carrier protein (ACP), which is one of
the intermediates in fatty acid biosynthesis, and the hydroxy group of dihydroxyace-
tone phosphate (DHAP) [26]. The fatty acid ester product of this reaction can then
undergo simple condensation and reduction reactions to form A-factor [26]. Apart from
AfsA, the rest of the components in the A-factor biosynthetic pathway are common
to most bacterial cells and it has been shown that the introduction of afsA results in
the synthesis of A-factor analogs in non- A-factor producing Streptomyces species and
even in E.coli [1]. A-factor production is limited by the small amount of the AfsA
substrate, C10 β-ketoacyl-ACP, leaked from the fatty acid biosynthetic pathway as well
as the presence of a regulatory feedback loop for afsA expression [19]. The afsA gene is
located towards the end of a linear chromosome, approximately 100 kb away from the
streptomycin biosynthetic gene cluster and due to the propensity of the ends of Strepto-
myces chromosomes to undergo large-scale mutations, A-factor production is found to
be unstable [39].
A-factor activates a signaling cascade by binding to its specific receptor named A-
factor Receptor Protein (ArpA), which is a repressor protein that regulates expression
of A-factor Dependent Protein (AdpA). AdpA in turn targets a host of genes involved
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Figure 1.6: Production of A-factor in S.griseus in relation to growth and secondary metabolite
(streptomycin) production. A-factor is produced in a growth-dependent manner and accumulates until
it reaches a critical concentration. Streptomycin production is initiated at this point and is followed by
the disappearance of A-factor. (Image from Horinouchi et al. [18])
in the morphological and physiological differentiation, termed as the AdpA regulon (see
Figure 1.7). In the absence of A-factor, ArpA binds to the promoter region of AdpA
and acts as the transcriptional repressor.
ArpA is a 276 amino acid protein encoded by the gene arpA and it binds to A-factor
with 1:1 molar ratio and a very low dissociation constant, Kd, of 0.7 nM [41]. The
crystal structure of ArpA has not been elucidated because of its tendency to aggregate
in solution, but CprB, a homolog of ArpA in S.coelicolor, has been crystallized and
structural comparisons suggest that they belong to TetR family of proteins [19] [44].
AdpA is a 405 amino acid protein which binds to the promoter regions of its target
genes and initiates transcription by recruiting the RNA polymerase and facilitating
isomerization of the RNA polymerase-DNA complex [48] [68]. Though the effect of
AdpA on the streptomycin biosynthesis, aerial mycelium formation and regulation of
its own transcription has been studied, knowledge of its regulation of other genes is
limited [60] [67] [27]. Studies indicate that AdpA is a global transcriptional activator
influencing the expression of more than 1000 genes in S.griseus [17]. In recent years,
genome analysis as well as crystallographic studies of AdpA DNA binding domain has
been performed towards the purpose of understanding the genes involved in AdpA
regulon and its regulatory mechanism [71]
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Figure 1.7: A-factor regulatory cascade in S.griseus. AfsA is the key enzyme in the A-factor biosyn-
thesis. In the presence of A-factor, the receptor protein, ArpA, is unable to repress AdpA expression.
AdpA directly regulates the expression of a host of genes involved in the morphological and physi-
ological differentiation. (Reprinted by permission from Macmillan Publishers Ltd: [Nature Reviews
Microbiology] (Flardh et al. [13]), copyright (2009).
1.7 Virginiae Butanolide System
Isolation and structural determination of virginiae butanolides (VBs) from Streptomyces
virginiae closely followed the discovery of A-factor [66] [36]. The VBs A-E differ in the
length and branching of their side chain (Figure 1.2). All induce the coordinated pro-
duction of two different antibiotics, virginiamycins M and S in S.virginiae at nanomolar
concentration [66].
Until recently, the role of the AfsA homolog in S.virginiae, BarX, in VB biosyn-
thesis was unclear with some results suggesting it exhibited only a regulatory role
[28]. However, support for its enzymatic activity has emerged since and it has been
shown that AfsA is capable of functionally complementing BarX in a barX -null mutant
[37]. Though the VB biosynthetic pathway is not as clearly understood as the A-factor
biosynthesis, feeding experiments and genetic studies indicate that VB biosynthesis in-
volves a different pathway from that of A-factor. The key difference is that instead
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of butenolide phosphate, DHAP (the substrate of AfsA), the substrate for BarX is a
butenolide, dihydroxy acetone (DHA). This results in the formation of a β-keto ester as
opposed to β-keto acid formed in the A-factor biosynthesis [51]. Also, unlike A-factor,
the keto group at C-6 is reduced to a hydroxyl group in VBs and the enzyme required
for catalyzing this additional reaction was identified as BarS1 [55].
Another major difference between A-factor and VB systems is that unlike afsA, barX
is located just upstream of its butyrolactone autoregulator receptor, BarA. BarA is a 232
amino acid protein almost exclusively present in the cytoplasm and is encoded by the
barA gene [65]. The regulatory cascade resulting from the binding of VB to BarA which
results in the induction of virginiamycin production in S.virginiae is not yet completely
understood, but the genes involved are found to be clustered in a 10 kb region known as
the virginiamycin regulatory island in the 77 kb virginiamycin biosynthetic gene cluster
[49] .
Binding of VB to BarA relieves the repression of barB, varS and varM genes [43].
BarA acts as a repressor for barX as well, thus repressing VB biosynthesis [42]. The
transcription of varS and varM allows cells to acquire virginiamycin resistance while
BarB temporarily represses the virginiamycin pathway specific regulatory gene, vmsR,
thereby delaying the virginiamycin biosynthesis [28]. BarA appears to transciptionally
control the vmsR expression as well [29]. VmsR, a SARP (Streptomyces Antibiotic Reg-
ulatory Protein) like protein, is in turn a regulator for regulatory genes which directly
control virginiamycin biosynthetic genes. A complete picture of the VB regulatory cas-
cade has not yet emerged, but it appears that BarA and BarX are higher level regulators
and both involved in a number of cell functions, including virginiamycin biosynthesis
and virginiamycin resistance [49].
1.8 Reporters for A-factor and VB
Antibiotic production is the assay currently used for studying the signaling activity of A-
factor and VB type signaling molecules. A-factor and its various synthetic analogs were
tested for biological activity in S.griseus by the induction of streptomycin production
[31]. It was observed that acyl derivatives of A-factor exhibited high biological activity
comparable to A-factor. GBLs from strains S.coelicolor and S.viridochromogenes, both
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IM-2 type GBL producers, were also found to be active in this assay with activity 2-3
fold less than A-factor. Similarly, synthetic analogs of VB were tested for their capability
to induce virginiamycin in S.virginiae [46]. Among 41 synthetic VB analogs tested, it
was observed that VB-C type compounds with heptyl and octyl side chains were 2.5 fold
more active than VB-C. A-factor type analogs were also tested for biological activity in
this assay and were found to induce 10 fold lower virginiamycin production than VB-C.
These results point to the specificity as well as the flexibility of the A-factor receptor,
ArpA, and the VB receptor, BarA, in detecting cognate and non-cognate signals. In all
instances it was found that receptors were most sensitive towards their cognate GBLs,
while some synthetic GBL derivatives and natural, non-cognate GBLs activate receptors
at higher concentrations. It is interesting to note that IM-2 type GBLs (SCB, Factor 1)
appear to be able to bind to the A-factor receptor and A-factor type GBLs are capable
of binding to the VB receptor. However, studies on the specificity of the binding of
different GBL types to the GBL receptors of each type is incomplete. For example,
the binding of IM-2 type GBLs with the VB receptor and that of VB type GBLs with
the A-factor receptor is not known. The different methodologies that were followed
for the detection and quantification of the binding to the different GBL receptors also
complicate comparison of results from different studies. Furthermore, the frequency
of signaling among Streptomyces through different types of GBLs and their role in
Streptomyces in natural environments has not yet been studied.
As discussed in previous section, antibiotic assays utilized in these GBL studies have
several drawbacks that limits their applications. On the other hand, the SCB reporter
assay for detecting IM-2 type GBL, SCB, was successfully used to study the binding of
all natural GBL types and their synthetic derivatives to the SCB receptor protein. The
simple format of this assay also allows for large-scale screenings to study the ecological
role of signaling. Therefore, similar assays which can detect the signaling of A-factor
and VB type GBL molecules by directly monitoring the binding to the receptor proteins
need to be developed for conducting meaningful comparative studies of the three types
of GBLs.
Chapter 2
Development of New A-factor
and VB Reporters
The new reporter systems for A-factor and VB described here were developed utilizing
the existing framework established by Hsiao et al. for the SCB reporter. Since the SCB
reporter utilized the fundamental GBL signaling mechanism as the basis for the assay,
this method was adapted to develop similar reporters for A-factor and VB type GBLs.
The scbR gene encoding the SCB receptor protein in the SCB reporter was substituted
with the orthologous genes arpA and barA which encodes the A-factor receptor protein,
ArpA, and VB receptor protein, BarA, respectively. Likewise, analogous to the cpkO
promoter region which acts as the target for ScbR in the SCB reporter, the promoter
region of AdpA was used as the DNA target for ArpA and the promoter region of BarB
as the target for BarA.
The cloning protocol, PCR amplified fragments of S.griseus arpA, promoter region of
adpA and S.virginiae barA, primers used to amplify these fragments, synthetic oligonu-
cleotides corresponding to promoter regions of barB and the plasmid vectors used in
the cloning, pIJ82 and pTE133, were kindly provided by Dr. Eriko Takano’s lab at
University of Groningen, Netherlands.
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2.1 Reagents
The pGEM-T Easy vector system and GoTaq Green Master Mix for Polymerase Chain
Reactions (PCR) were purchased from Promega (Madison, WI). Restriction enzymes,
T4 DNA ligase, T4 Polynucleotide Kinase, Phusion High-Fidelity DNA Polymerase
and Antarctic phosphatase were obtained from New England Biolabs (Ipswich, MA).
Kits for gel purification and plasmid mini preps were purchased from Qiagen (Valencia,
CA) and Invitrogen (Grand Island, NY), respectively. The UltraClean Microbial DNA
Isolation Kit from Mo Bio (Carlsbad, CA) was used for extracting genomic DNA from
Streptomyces. Sanger DNA sequencing of all the samples was done at the Biomedical
Genomics Center (BMGC, University of Minnesota). Primers were synthesized either
at Sigma-Aldrich (St. Louis, MO) or the BMGC.
2.2 Bacterial Strains and Growth Conditions
All strains and plasmids used in this study are listed in Table 2.2. The Streptomyces
strains were stored as 20% sterile glycerol spore stocks at −20◦C and E.coli strains in
50% glycerol at -80◦C. All Streptomyces coelicolor strains were grown at 30◦C on the
Soy Flour Mannitol (SFM [33]) agar medium for 5-7 days for spore stock preparation and
on the SMMS agar (Supplemented Minimal Medium, Solid [33]) for the GBL extraction.
Streptomyces strains were grown at 30◦C with continuous shaking at 250 rpm for 3-5
days in the ISP2 broth for DNA isolation and in the Yeast Extract Malt Extract medium
(YEME [33]) for measurement of optical density in liquid culture . The SCB reporter
strain (LW16::pTE134) was grown under 50 µg/ml hygromycin selection and S.coelicolor
scbA scbR double deletion mutant LW16 was grown on SFM with 50 µg/ml apramycin.
E.coli ET12567/pUZ8002 was propagated in the LB medium with 50 µg/ml kanamycin
and 25 µg/ml chloramphenicol. Competent cells of E.coli DH5α were prepared using
the Inoue method for the preparation and transformation of E.coli ultra competent cells
and plasmids pTE133 and pIJ82 were propagated by transforming into E.coli DH5α and
selectively growing transformants on LB plates with 100 µg/ml ampicillin and 50 µg/ml
hygromycin respectively [52].
19
2.3 Construction of A-factor and VB Reporter Strains
The arpA, promoter adpA and barA PCR products were first cloned into pGEM-T
Easy vectors. The list of primers is given in Table 2.1. Since the PCR products were
blunt ended, an A-tailing procedure as described in the pGEM-T cloning manual was
performed prior to ligating with the pGEM-T Easy vector according to the cloning
protocol. Several independent clones were selected and the correct insertion confirmed
using PCR and subsequent sequencing of the purified PCR product in both forward and
reverse directions using the appropriate primers.
2.3.1 Construction of pTE133-arpA and pTE133-barA
The plasmid pTE133 which carries a promoterless kanamycin gene, neo, was digested
with the combination of enzymes HindIII and SacI. This reaction produced three frag-
ments of lengths approximately 4 kb, 1257 bp and 75 bp. The digest mix was separated
by electrophoresis in ultrapure agarose gel and the largest of the fragments (4 kb) was
purified from the gel. The pGEM-T vectors containing arpA and barA genes were also
digested with the combination of HindIII and SacI and arpA (1129 bp) and barA (1024
bp) fragments purified from the agarose gel. The purified DNA fragments were used
in the ligation reaction using T4 DNA ligase and the ligation mix was used to trans-
form E.coli DH5α. The transformed clones were selected on LB-ampicillin plates and
the successful insertion was confirmed by the DNA isolation and PCR amplification of
inserted genes.
2.3.2 Introduction of promoter-adpA into pTE133-arpA and promoter-
barB into pTE133-barA
The pTE133-arpA and pTE133-barA plasmids were digested with SacI to linearize the
plasmid. To avoid the self-circularization of the plasmid during ligation step, the lin-
earized vector was treated with Antarctic phosphatase. The pGEM-T vector carrying
the promoter of AdpA gene was cleaved with SacI as well, giving rise to a 384 bp frag-
ment which was purified through gel electrophoresis. Synthetic oligonucleotides for the
promoter of BarB gene were designed so that sticky ends compatible with SacI overhangs
remained after their annealing. To anneal the oligonucleotides, equimolar amounts of
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(a) pTE133-arpA (b) pTE133-barA
Figure 2.1: Schematic representation of pTE133-arpA and pTE133-barA plasmids showing the orien-
tation of the A-factor receptor protein (ArpA) encoding gene, arpA, the VB receptor protein (BarA)
encoding gene, barA and the kanamycin resistance gene, neo. HindIII and SacI restriction sites used in
the cloning of genes are also shown.
forward and reverse molecules were mixed in a microcentrifuge tube, heated for 2-3 min
at 95◦C in the presence of T4 DNA ligase buffer and allowed to slowly cool down to
the room temperature. The resulting double-strand molecules were treated with T4
Polynucleotide Kinase for addition of 5′-phosphates to allow subsequent ligation. The
linearized pTE133-arpA and pTE133-barA were then ligated with promoter-adpA and
the annealed promoter-barB respectively, and transformed into E.coli DH5α.
This ligation resulted in the formation of two kinds of plasmids with the two genes
ligated in either the same or opposing orientations. Since the repressor and promoter
genes exist divergently in the native Streptomyces sp., the constructs with opposing ori-
entation of the inserted genes were selected through PCR amplification with appropriate
primer pairs.
2.3.3 Construction of integrating vector and introduction into LW16
The two plasmids obtained in the previous step were cleaved with BglII to release the
cassettes containing the arpA/barA genes and the kanamycin resistance gene under con-
trol of the corresponding promoter and the cassettes were purified from the agarose gel.
The integrating vector pIJ82 was cleaved with BamHI and treated with alkaline phos-
phatase. The linearized pIJ82 was then ligated with the cassettes and the recombinant
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(a) pTE133-arpA-promoter adpA (b) pTE133-barA-promoter barB
Figure 2.2: Schematic representation of pTE133-arpA-promoter adpA and pTE133-barA-promoter
barB plasmids showing the orientation of (a) arpA, promoter-adpA (adpAp) and neo genes in the
A-factor reporter construct and (b) barA, promoter-barB (barAp) and neo genes in the VB reporter
construct. The HindIII and SacI rstriction sites used in cloning are also shown.
plasmids transformed into E.coli DH5α. The plasmids were then introduced into the
methylation-deficient E.coli strain ET12567 containing the RP4 derivative pUZ8002 and
transferred to S.coelicolor LW16 by conjugation [14, 33]. Figure 2.3 gives a schematic
maps of the final plasmids.
Single-crossover exconjugants were selected on SFM plates containing 50 µg/ml hy-
gromycin and 25 µg/ml nalidixic acid, to obtain transconjugants LW16::pIJ82-arpA-
promoter adpA-neo and LW16::pIJ82-barA-promoter barB -neo. The A-factor and VB
reporter conjugants obtained were grown in ISP2 + 50 µg/ml hygromycin liquid medium
for the DNA isolation and the plasmid integration was confirmed by PCR with primers
attB-forw and attP-rev which gave an amplified product of 0.8 kb corresponding to the
inserted region. Further, PCR with attB-forw, neo-rev primer pair was performed to
amplify and confirm the sequence of the receptor, promoter and neo genes inserted in
the cassette. The reporter strains were grown on SFM + 50 µg/ml hygromycin solid
medium for the spore stock preparation. The harvested spores were grown in ISP2 + 50
µg/ml hygromycin liquid medium for the post-sporulation DNA isolation and analysis.
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(a)
(b)
Figure 2.3: Schematic map of the A-factor and VB reporter plasmids prior to chromosomal integration.
The figures (a) and (b) show the location of inserted genes in the A-factor reporter plasmid, pIJ82-arpA-
promoter adpA-neo, and the VB reporter plasmid, pIJ82-barA-promoter barB-neo, respectively. The
hygromycin resistance gene hyg, the selectable marker for the plasmids, and int gene (phiC31 integrase)
for chromosomal integration of plasmids based on attP attachment site (phiC31 attP site) are also
shown.
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Table 2.1: Primers used in this study
Primer/Oligonucleotide Sequence (5’-3’)
ArpA-SacI-forw CTGAGAGCTCACGGTTTCCGGACAGACCGATG
ArpA-HindIII-rev CTATAAGCTTCGTGATCCGCCATGTCCTC
BarA-SacI-forw CTCAGAGCTCATAGAAACCGATCTCGCGGGAAC
BarA-HindIII-rev CTCGAAGCTTGATACAAACCGTCAGACCCGATTGC
AdpA-SacI-forw CAGTGAGCTCGGATACAGCACACGCAACCAATG
AdpA-SacI-rev CTATGAGCTCGTTCGCGTCTCCCTGGTCCTTAC
Prom-BarB-rev CTCGGTTTGCTGAACGTCTC
attB-forw TTCTGGAAATCCTCGAAGGC
attP-rev GTAAGCACCCGCGTACGTGT
neo-rev TGTCTGTTGTGCCCAGTCAT
Prom-BarB-for (oligo) CGCAGCACACGAGACGTTCAGCAAACCGAGCG-
GTTCGCTTGCCTCAGCCAAACGGTG-
CACGTCAGGAGTTGGAGCT
Prom-BarB-rev (oligo) CCAACTCCTGACGTGCACCGTTTGGCTGAG-
GCAAGCGAACCGCTCGGTTTGCT-
GAACGTCTCGTGTGCTGCGAGCT
Table 2.2: Strains and plasmids used in this study
Strain/Plasmid Genotype/Characteristics Reference/Source
S.coelicolor
strain M145
Wild type S.coelicolor strain
capable of producing SCBs
Kindly provided by
Dr. Eriko Takano at
University of
Groningen
S.coelicolor
strain LW16
scbA scbR double deletion mutant Hsiao et al. [23].
Kindly provided by
Dr. Eriko Takano at
University of
Groningen
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Table 2.2: Strains and plasmids used in this study (contd.)
Strain/Plasmid Genotype/Characteristics Reference/Source
S.coelicolor strain
LW16::pTE134
SCB reporter used in kanamycin
resistance bioassay
Hsiao et al. [23].
Kindly provided by
Dr. Eriko Takano at
University of
Groningen
E.coli
ET12567/pUZ8002
Methylation deficient E.coli
ET12567 carrying the
non-transmissible plasmid pUZ8002
containing oriT from the
IncP-group plasmid RP4. Used for
site-specific chromosomal
integration of plasmid DNA
through conjugation into
Streptomyces
Flett et al. [14].
Kindly provided by
Dr. Eriko Takano at
University of
Groningen
E.coli DH5α Host for cloning: F- 80dlacZ M15
(lacZYA-argF ) U169 recA1
endA1hsdR17(rk-, mk+)
phoAsupE44 -thi-1 gyrA96 relA1
Kindly provided by
Dr. Micah Gearhart
at the University of
Minnesota
E.coli
DH5α:pTE133
Plasmid pTE133 transformed into
E.coli DH5α
This study
E.coli
DH5α:pIJ82
Plasmid pIJ82 transformed into
E.coli DH5α
This study
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Table 2.2: Strains and plasmids used in this study (contd.)
Strain/Plasmid Genotype/Characteristics Reference/Source
S.coelicolor strain
LW16::pIJ82-
arpA-promoter
adpA-neo
A-factor reporter This study
S.coelicolor strain
LW16::pIJ82-
barA-promoter
barB -neo
VB reporter This study
S.virginiae Wild type capable of producing
virginiae butanolides
Kindly provided by
Dr. Eriko Takano at
University of
Groningen
S.griseus Wild type capable of producing A-
factor
Kindly provided by
Dr. Eriko Takano at
University of
Groningen
pGEM-T Easy High-copy-number vector linearized
with poly-T tail, containing the
α-peptide coding region of the
enzyme β-galactosidase. Insertional
inactivation of the α-peptide allows
identification of recombinants by
blue/white screening on indicator
plates
From Promega,
Madison, WI
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Table 2.2: Strains and plasmids used in this study (contd.)
Strain/Plasmid Genotype/Characteristics Reference/Source
pGEM-T-arpA arpA in vector This study
pGEM-T-
promoter
adpA
promoter adpA in vector This study
pGEM-T-barA barA in vector This study
pTE133 Plasmid carrying the promoterless
kanamycin gene, neo, AmpR
Hsiao et al. [23].
Kindly provided by
Dr. Eriko Takano at
University of
Groningen
pTE133-arpA Plasmid with arpA-neo casette,
AmpR
This study
pTE133-barA Plasmid with barA-neo casette,
AmpR
This study
pTE133-arpA-
promoter
adpA
Plasmid with arpA-promoter
adpA-neo casette, AmpR
This study
pTE133-barA-
promoter
barB
Plasmid with barA-promoter
barB -neo casette, AmpR
This study
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Table 2.2: Strains and plasmids used in this study (contd.)
Strain/Plasmid Genotype/Characteristics Reference/Source
pIJ82 5.9 kb integrating vector containing
phiC31 attP site, hygR
Hsiao et al. [23].
Kindly provided by
Dr. Eriko Takano at
University of
Groningen
pIJ82-arpA-
promoter
adpA-neo
Integrating vector with
arpA-promoter adpA-neo , hygR
This study
pIJ82-barA-
promoter
barB -neo
Integrating vector with
barA-promoter barB -neo, hygR
This study
2.4 Kanamycin Resistance Bioassay
The published protocol for the kanamycin resistance bioassay with the SCB reporter
was optimized for our laboratory conditions. The concentration of kanamycin and pH
of the medium were optimized for the clear visualization of positive results. This was
achieved by performing the assays in media prepared with kanamycin concentrations
varying from 3 - 7.5 µg/ml and the pH adjusted from 6.3 - 6.8 by addition of 100 mM
HCl, while keeping the amount of SCB extract constant. The crude SCB extract from
S.coelicolor M145 was prepared following the method given by Hsiao et al. to use as a
positive control for the kanamycin resistance bioassay [22]. The M145 strain was grown
on SMMS medium for 5 days and extracted using ethyl acetate. The ethyl acetate was
removed with rotary evaporator and the SCB extract re-suspended in 100% HPLC-
grade methanol at a concentration of approximately 10 µl per plate extracted. The
extract was tested for positive activity by spotting on Difco Nutrient Agar (DNAgar)
plates containing 3 - 5 µg/ml kanamycin which was spread with SCB reporter spores at
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a concentration of 2×106 spores in 100 µl volume. Methanol was used as the negative
control. A positive result was identified by the appearance of kanamycin resistant
colonies around the spot after incubation at 30◦C for 48 hrs. Absence of any growth
around the spot (except some spontaneous mutants randomly dispersed on the plate)
indicated a negative result.
2.4.1 Screening extract libraries with the SCB and A-factor reporters
A pilot extract library was created by extracting seven isolates from a Streptomyces
sp. strain collection and S.griseus according to the rapid GBL extraction protocol (as
described in the previous section). The strains were grown on SMMS medium for 3 days
at 30◦C and extracted with ethyl acetate. All extracts were tested with the SCB and
A-factor reporters in the kanamycin resistance bioassay using the previously described
protocol.
The SCB and A-factor reporters were also screened with 37 extracts from a Strepto-
myces liquid culture extract library. Extracts used in the screening were prepared from
liquid cultures grown for 5 days in ISP2 broth with shaking and extracted with ethyl
acetate. The solvent phases were dried using a rotary evaporator and reconstituted in
methanol at a standard concentration (10 mg/mL).
2.4.2 Modified kanamycin resistance bioassay: overlay method
In order to circumvent the lengthy GBL extraction process and increase the through-
put, the protocol for the kanamycin resistance bioassay was modified to enable testing
of live Streptomyces cultures with the GBL reporters. The strains to be tested with
the reporters were grown on solid ISP2 medium at 30◦C for 1-3 days. At the end of
the growing period, cultures were overlaid with 10 ml of 1% nutrient agar containing
4.5 µg/ml kanamycin (pH 6.4 unadjusted), seeded with approximately 2 × 105 cfu/ml
of the reporter spores. These plates were then incubated at 30◦C for 48 hours. A non-
inoculated ISP2 plate was also overlaid to serve as a negative control for the assay. The
plates were observed at the end of the incubation period for the measurement of growth
of the reporter around the Streptomyces test colonies.
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Screening a Streptomyces collection with A-factor and SCB reporters in the
overlay assay
The overlay method was utilized to screen a collection of 40 Streptomyces isolates with
the A-factor and SCB reporters for investigating signaling activity. The isolates were
selected for screening from a Streptomyces strain collection based on their ability to
grow well on the ISP2 medium at 30◦C. In all cases, 2 µl of the frozen spore stocks
were spotted on the ISP2 plate for starting the culture. The strains isolated from a
variety of environments were represented in the collection. To account for the potential
chemical instability of signaling molecules in the ISP2 medium as well as the temporal
variability in signal production, 1, 2 and 3 day cultures of each isolate was tested with
the reporters.
Since many Streptomyces isolates are known to produce antibiotic-modifying or
degradative enzymes, further control experiments were designed to monitor and in-
activate any kanamycin degrading activity of the test isolates that could interfere with
the kanamycin resistance overlay bioassay. To detect the kanamycin degrading activity,
the reporter spores were replaced with S.coelicolor strain LW16 spores under identical
conditions in the kanamycin resistance overlay assay of the test isolates. Additionally,
the kanamycin resistance overlay protocol was modified to include the exposure of the
Streptomyces test cultures to chloroform in order to eliminate the effect of kanamycin
modifying enzymes produced by the test isolates. Filter paper soaked with approxi-
mately 3 ml chloroform per plate was placed inside the lid of glass petri dishes contain-
ing the growing isolates. The plates were kept inverted in the fume hood for 3 hours
allowing the chloroform vapors to saturate the strains. The chloroform vapors were
removed by leaving the plates open in a fume hood for 1 hour. The cultures were then
overlaid with the A-factor and SCB reporters and the S.coelicolor LW16 control strain
in the kanamycin resistance overlay assay.
2.4.3 Liquid culture assay
Preliminary liquid culture studies were performed with the reporters in an attempt
to develop a liquid-based assay for high-throughput screening. In 200 ml erlenmeyer
flasks containing 50 ml YEME medium, 1×105 cfu/ml reporter spores were grown with
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4.5 µg/ml kanamycin and 0.1 µl/ml microbial extract. Separate control experiments
were performed without addition of kanamycin and microbial extracts to the medium.
All flasks were incubated at 30◦C with shaking at 250 rpm. At the end of the incubation
period, optical density of cultures was measured using a spectrophotometer. The liquid
culture volume was also reduced to 200 µl to conduct the assay in the 96-well format,
keeping the other parameters identical. The plates were incubated with shaking at 250
rpm and the OD600 was measured using a plate reader.
Chapter 3
Results and Discussion
3.1 Genetic Analysis of A-factor and VB Reporters
A-factor and VB reporters were assembled successfully following the published protocol
for the SCB reporter system [23]. Each step of the DNA recombination was accompanied
by PCR amplification and DNA sequencing of the inserted genes using appropriate
primers in order to ensure the intact and error free insertion of genes in the selected
clones.
To test the genetic stability of the reporter stains, a comparative PCR analyis of
mycelial genomic DNA before and after sporulation was performed. The PCR with
the attB-forw, attP-rev primer pair was used to confirm chromosomal integration based
on attachment sites and the PCR using the attB-forw, neo-rev primer pair was used
to amplify the region from the attachment site in the genome to the receptor, pro-
moter and neo genes inserted in the cassette. The agarose gel electrophoresis analysis
of these PCR product bands showed that the constructs were genetically unstable and
underwent spontaneous insertion and deletion during the process of sporulation (Fig-
ure 3.1). HindIII restriction digestion of the purified PCR product further confirmed
the occurrence of these mutations in DNA isolated post sporulation. Figure 3.1 a gives
a schematic of the orientation of genes after chromosomal integration and the primers
used in PCR. The agarose gel images in Figure 3.1 b and 3.1 c show the effect of
mutation on DNA fragment size.
In order to address the genetic instability, selective pressure in the SFM medium
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(a)
(b) (c)
Figure 3.1: Agarose electrophoresis analysis of the A-factor and VB reporter genomes for inserted
genes. The image (a) is a schematic of the S.coelicolor genomic DNA showing the expected orientation
of genes after integration. The arrows indicate the location of primers that were used in PCR to confirm
the integration. The images (b) and (c) are the agarose gels of PCR products and restriction digests
on the A-factor and VB reporter (AFR and VBR respectively) genomic DNA showing the effect of
spontaneous mutation in post-sporulated DNA. The PCR with the attB-forw, attP-rev (primer pair I)
was used to confirm chromosomal integration and gives a 0.8 kb product with both A-factor and VB
reporters (AFR I and VBR I in the image). The PCR with the attB-forw, neo-rev (primer pair II,
AFR II and VBR II in the image) forms a product spanning the chromosomal attachment site and the
inserted genes. The expected size of this PCR product is approx. 3.9 kb for the AFR and 3.5 kb in
the case of the VBR. The image (b) confirms successful chromosomal integration and also shows a clear
difference in the PCR product size from amplification of the A-factor and VB reporter DNA with the
attB-forw, neo-rev primer pair before sporulation (BS) and post sporulation (PS). The gel image (c) is
the HindIII restriction digest of this product and depicts the differences in the size of fragments before
and after sporulation, further confirming the spontaneous insertion and deletions in this region.
(b) lanes: 1- DNA ladder, 2- Primer pair I PCR of AFR PS (AFR I) 3- Primer pair I PCR of VBR PS
(VBR I), 4- DNA ladder, 5- Primer pair II PCR of AFR BS (AFR II BS), 6- Primer pair II PCR of
AFR PS (AFR II PS), 7- Primer pair II PCR of VBR BS (VBR II BS), 8- Primer pair II PCR of VBR
PS (VBR II PS);
(c) lanes: 1- DNA ladder, HindIII digest of the primer pair II PCR product of 1- AFR PS (AFR II PS),
2- AFR BS (AFR II BS), 3- VBR PS (VBR II PS), 4- VBR BS (VBR II BS);
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was increased to 75 µg/ml hygromycin while growing the A-factor and VB reporters for
the spore stock preparation. The PCR analysis showed that this stabilized the A-factor
reporter, but failed to stabilize the VB reporter (see Figure 3.2). The orientation and
integrity of all the inserted genes in the A-factor reporter was confirmed by sequencing
the purified product from the attB-forw, neo-rev primer pair PCR reaction with primers
for arpA, promoter adpA and neo genes. The selective pressure in the medium for the
spore stock preparation was further increased to 100 µg/ml hygromycin in an effort to
stabilize the VB reporter spores. However, it was observed that the inserted genes were
still unable to be amplified from the mycelial DNA post sporulation. Since the VB
reporter spores could not be stabilized, only the A-factor reporter spores were analyzed
for functionality using the kanamycin resistance bioassay.
Figure 3.2: The effect of increased hygromycin selection on the A-factor and VB reporter DNA.
The gel image demonstrates the stabilization of the A-factor reporter (AFR) spores after increasing
hygromycin selective pressure to 75 µg/ml and illustrates its lack of effect in the case of the VB reporter
(VBR). The genomic DNA extracted before and after the sporulation was PCR amplified with attB-
forw, attP-rev (primer pair I, expected product size 0.8 kb) and attB-forw, neo-rev (primer pair II,
expected product size 3.9 kb for AFR and 3.5 kb for VBR) primers and compared. Lanes are: 1- DNA
ladder, 2- Primer pair I PCR of AFR Before Sporulation (BS), 3- Primer pair II of AFR BS, 4- Primer
pair I PCR of AFR Post Sporulation (PS), 5- Primer pair II PCR of AFR PS, 6- Primer pair I PCR of
VBR BS, 7- Primer pair II PCR of VBR BS, 8- Primer pair I PCR of VBR PS(no product), 9- Primer
pair II PCR of VBR PS (no product).
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3.2 Bioassays with the A-factor and SCB Reporters
3.2.1 Effect of pH on the reporters
It was observed that the pH of the commercial Difco nutrient agar media used in the
kanamycin resistance bioassay varied from pH 6.4 to 6.8 and this had a significant effect
on the response of the SCB reporter. Testing the SCB reporter with identical amounts
of M145 extract on media of pH ranging from 6.8 - 6.3 (see Figure 3.3) showed most
intense response with minimal background growth at pH 6.4. The growth of background
mutants increased considerably at pH 6.3 suggesting that the lower pH affected the
stability and thereby the potency of kanamycin in the medium.
(a) pH 6.8 (b) pH 6.7 (c) pH 6.6
(d) pH 6.5 (e) pH 6.4 (f) pH 6.3
Figure 3.3: The effect of the pH of the medium on the response of the SCB reporter to identical
amounts of positive control M145 extract. All plates were prepared with Difco Nutreint Agar and
kanamycin (4.5 µg/ml). The reporter growth halo starts appearing at pH 6.5 and showed the most
robust growth with minimal background at pH 6.4. Lower pH values led to both increased growth of
the reporter and larger number of random mutants (observed as the growth in areas away from where
the extract was spotted). (Note: With higher amount of M145 extract, growth of the SCB reporter can
be observed at higher pH.)
The pH of the medium was found to have an effect on the A-factor reporter as well.
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As observed in the case of the SCB reporter, lower pH levels corresponded to higher
levels of background growth of the reporter in the absence of any signaling molecule
(data not shown). At higher pH, lower kanamycin concentrations resulted in fewer
mutants while at lower pH, higher kanamycin concentration was required. In contrast
with the SCB reporter conditions, at 4.5 µg/ml kanamycin and pH 6.4, the A-factor
reporter exhibited significant background and therefore for testing the A-factor reporter,
the optimal pH was found to be pH 6.8.
3.2.2 Kanamycin resistance overlay bioassay
Testing the A-factor reporter
To positively confirm the activity of the A-factor reporter, it has to be tested with
A-factor in the kanamycin resistance bioassay. The extraction of A-factor from the
producing organism, S.griseus, was attempted for this purpose. Since conventional
large-scale liquid culture extraction was not feasible, S.griseus solid culture crude extract
was prepared following a published method [22]. Different media conditions were tested
for successfully extracting A-factor from solid culture. S.griseus was grown in both
complex medium (nutrient agar) and minimal medium (SMMS) and the cultures were
extracted at different time points (24 hrs, 48 hrs and 72 hrs). All extracts failed to elicit
positive response when tested with the A-factor reporter.
The lack of standard signal compounds and a reliable method for isolation of A-factor
required development of an alternative method to test the A-factor reporter. An overlay
bioassay was subsequently designed to test the live culture of S.griseus directly with the
A-factor reporter in the kanamycin resistance bioassay. Since A-factor is produced in a
time sensitive manner and might not be stable in complex growth media such as ISP2,
a time course experiment was designed. The S.griseus cultures were grown for 1, 2, 3, 4
and 5 day time points and tested with the A-factor reporter. The A-factor reporter was
observed to grow around the S.griseus colony at all time points tested as shown in the
Figure 3.4. These results initially suggested that A-factor was produced by S.griseus
starting from day 1 and the A-factor reporter was able to detect it in the kanamycin
resistance overlay bioassay. Similar results were observed when the SCB reporter was
tested in the kanamycin resistance overlay bioassay with S.coelicolor M145 strain (data
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not shown).
Figure 3.4: Results from the kanamycin resistance overlay assay of S.grisues with the A-factor re-
porter. The images (a - e) show 1 - 5 day S.griseus cultures overlaid with the reporter in media
containing kanamycin (4.5 µg/ml). The growth halo appear to be most dense around 1 day and 2 day
S.griseus cultures and decrease thereafter.
Screening a Streptomyces strain collection with the A-factor and SCB re-
porters using the kanamycin resistance overlay method
The apparent ease at which the kanamycin resistance overlay assay can be performed
with the A-factor and SCB reporters led to the screening of 39 Streptomyces strains
from a Streptomyces strain collection and the VB producing strain, S.virginiae, with
the reporters. S.virginiae did not activate either of the reporters. Twenty out of the
39 strains (51%) from the strain collection were able to activate either the A-factor
reporter or the SCB reporter on one or more time points. In most cases the same
isolates activated both the reporters, but exceptions were also observed. Some strains
exclusively activated either the A-factor reporter or the the SCB reporter. It was also
found that in the isolates which activated both the reporters, activation of one reporter
coincided temporally with the activation of the other reporter. Though this could be
considered an indication that the GBL-like molecules produced by these strains were
able to bind to both the A-factor and SCB receptors, a further control experiment was
performed to verify that the observed results were true positives.
Earlier results on the effect of pH of the medium on kanamycin and the subsequent
effect this has on the response of the reporter strains in the kanamycin resistance bioas-
say pointed to the possibility that factors affecting kanamycin might be present in the
overlay bioassay. In order to test this hypothesis, all the strains which caused reporter
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growth at 2 day time points in the kanamycin resistance overlay bioassay were selected
and the assay repeated using S.coelicolor LW16 strain instead of the reporter strains.
S.coelicolor LW16 strain lacks the kanamycin resistance gene and cannot grow in the
presence of kanamycin. It is physiologically similar to the reporter strains in all other
aspects and thus it is an ideal control strain for testing the presence of factors that
could be compromising the overlay bioassay. Including S.coelicolor and S.griseus, 15
strains were tested with the LW16 strain in the kanamycin resistance overlay control
experiment. It was observed that with the exception of one strain (CES-233), all tested
strains caused LW16 to form a growth halo similar to those formed by the reporters (see
Figure 3.5 for a sample comparison of the growth of LW16 and the A-factor reporter
caused by a test strain).
(a) (b)
Figure 3.5: Comparison of the A-factor and the strain LW16 growth halo around a test strain,
Streptomyces sp. CES-311. The images (a) and (b) show the growth of the A-factor reporter and LW16
strain around a 2 day colony of CES-311 in the kanamycin resistance overlay bioassay under identical
conditions. The growth halo appear to be denser around the reporter compared to strain LW16.
The results showed that the growth of the reporters around the colonies of tested
strains were not caused by the signal detection and the subsequent kanamycin resis-
tance induction, but due to the tested strains themselves modifying kanamycin in the
surrounding medium. Kanamycin is an aminoglycoside antibiotic and enzymatic modifi-
cation is the most common type of aminoglycoside resistance mechanism [54]. Aminogly-
coside modifying enzymes have been reported from several Streptomyces sp. including
S.griseus [54]. The results of the control experiment suggested that kanamycin modify-
ing enzymes are widespread among Streptomyces and caused interference to the signal
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reporting process by the GBL reporters.
Chloroform treatment of Streptomyces cultures in the overlay assay
In spite of maintaining identical assay conditions and spore density in the overlay,
differences were observed in the density of the halo produced by the reporter strains
and LW16 around the test strains. As seen in Figure 3.5 a and 3.5 b, the halo formed by
the A-factor reporter was significantly denser than LW16 strain. This pointed towards
the possibility of a combination effect in which kanamycin in the medium is inactivated
due to the combined activity of kanamycin degradation by the test strain and the signal
detection by the reporter strain. To test this hypothesis, the overlay protocol was
modified to include a 2 hr exposure of the test strains to chloroform before overlaying
with the reporters and LW16. The exposure to chloroform is a widely utilized technique
in overlay bioassays to kill test strains prior to overlay. All strains that caused reporter
growth at all time points were re-tested with the A-factor reporter, SCB reporter and
LW16 strain using the modified overlay protocol. The results from chloroform treatment
are compiled in Table 3.1. The exposure to chloroform prevented the growth halo by
both the reporters and LW16 in nine out of 22 strains tested. This included the positive
control strains, S.coelicolor M145 and S.griseus. Among the 13 test strains which caused
the growth of either of the reporters, nine strains clearly caused the growth of LW16 as
well.
Although there appeared to be variations in the densities of halo produced by LW16
and the reporters, it was not sufficient to differentiate between true signal detection and
false positives. It was concluded that the variations observed in the density of halos
produced by the test strains with the SCB reporter, A-factor reporter and LW16 in
the overlay bioassay were artifacts caused by variations in spore density of the stocks,
amount of overlaid kanamycin agar, etc. The reporters appeared to grow in very low
numbers around the remaining four strains and were scored as weakly positive. The over-
all results showed that chloroform treatment did not sufficiently inhibit the kanamycin
degrading or modifying enzymes among the Streptomyces stains tested. Additionally,
the inability of even the positive control strain, S.coelicolor M145 to induce the SCB
reporter after chloroform treatment indicated that live Streptomyces cultures do not pro-
duce sufficient amounts of signaling molecules to be clearly detected using this method.
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Therefore, additional screenings were focused on concentrated extracts from cultures.
Treatment Number of strains that
caused the reporter
growth in the presence
of kanamycin
Number of strains that
caused the growth of
strain LW16 in the pres-
ence of kanamycin
Without chloro-
form exposure
22 out of 42 14 out of 15
With chloroform
exposure
13 out of 22 9 out of 22
Table 3.1: Results from testing the strain collection (including S.coelicolor M145, S.griseus and
S.virginiae) with the A-factor and SCB reporters and strain LW16 in the kanamycin resistance overlay
bioassay, showing the effect of chloroform treatment. The table shows the number of strains that caused
either of the reporters to grow in the presence of kanamycin out of the total number of strains tested,
with and without chloroform treatment. The total number of strains tested with the negative control
strain LW16 and the number of strains that caused LW16 growth in kanamycin medium is also given
(Note: Only 15 out of 22 strains that caused the growth of the reporters were tested with LW16 strain
in the assay without chloroform treatment).
3.2.3 Screening of a Streptomyces extract library with the SCB and
A-factor reporters
Two crude extract libraries were tested with the A-factor and SCB reporters to screen
for signaling activity. A small extract library was prepared from 3 day minimal media
solid cultures of seven strains from Streptomyces strain collection as described in Hsiao
et al. for testing with the SCB reporter [23]. Out of seven extracts, the extract of strain
CES-233, an isolate from Mississippi river sediment, induced the growth of the SCB
reporter (see Figure 3.6 a) in the kanamycin resistance bioassay, suggesting that CES-233
produces GBL like compounds capable of binding to the SCB receptor protein. The A-
factor and SCB reporters were also used to screen a liquid culture extract library. Ethyl
acetate extracts from 5-day liquid cultures of 37 Streptomyces strains were screened
with the reporters in the kanamycin resistance bioassay. The extract from a Florida
marine sediment isolate CES-015 was the sole sample which induced the SCB reporter
(see Figure 3.6 b).
Neither of the two extracts that caused the growth of the SCB reporter induced
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(a) (b)
Figure 3.6: Induction of the SCB reporter by extracts of Streptomyces isolates (a) CES-233 (solid
culture extract) and (b) CES-015 (liquid culture extract) in the kanamycin resistance bioassay per-
formed under identical conditions. The significantly larger halo observed with CES-233 solid culture
extract could be due to higher concentration of the extract or more specific binding of reporter inducing
compounds compared to CES-015 liquid culture extract.
similar response in the A-factor reporter, suggesting that either the observed results
are specific to the SCB reporter. However, it could also be indicative of the inability
of A-factor reporter assay to detect signaling molecules. The significantly larger halo
observed with the CES-233 solid culture extract could be indicative of either higher
concentration or higher binding affinity of the SCB receptor binding compounds in the
extract compared to CES-015 extract. Both the strains have been previously char-
acterized for antibacterial and anti-fungal activities and CES-015 is known to exhibit
antibacterial and anti-fungal activity whereas CES-233 is active against Gram positive
bacteria (unpublished data). The role of the SCB reporter inducing compound in this
observed antibiotic and anti-fungal activity or other hitherto unknown behaviors in
these strains is a topic for further investigation.
The results from the screening of the extract library points to several complexities
associated with the search of GBL molecules. The SCB reporter was induced by merely
4.5% (2 out of 44) of the tested samples, while the A-factor reporter was induced by none.
The absence of reporter induction by a majority of the extracts, most of which have
been previously shown to have significant bioactivity against bacteria and fungi and are
good candidates for potential signaling activity, could be due to several reasons. First,
the strains from which the extracts were prepared might not be producing signaling
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molecules capable of binding to the GBL receptor proteins in the reporters. Other
possibilities include the non optimal culture conditions, medium components, method
of extraction and concentration of extracts. All extracts in the extract library were
prepared from small scale cultures. While small scale solid culture extraction has been
proven to be successful for S.coelicolor GBLs, it failed to produce an active extract in the
case of S.griseus. For GBL extraction from liquid cultures, large volumes in the range
of hundreds of liters are typically required, whereas the liquid culture library used in
this screening was prepared from much smaller volumes. The results observed could be
an indication of either the A-factor reporter not detecting A-factor successfully or none
of the tested extracts containing A-factor like GBLs. It should be noted that A-factor
is the only known GBL of its type, so A-factor type GBLs might be less commonly
produced compared to SCB type.
3.2.4 Liquid culture studies with the SCB reporter
In order to expand the kanamycin resistance assay into a robust, high throughput for-
mat, preliminary liquid culture studies were performed with the SCB reporter. The SCB
reporter was grown in liquid culture under various conditions and it was found that the
reporter was successfully induced in liquid culture in the presence of kanamycin when the
positive control S.coelicolor M145 extract was added. The growth of the SCB reporter
was quantified using optical density measurements (Table 3.2).
Sample Calculated OD
Positive control: SCB reporter 2.682
Negative control: SCB reporter + kanamycin 0.000
SCB reporter + kanamycin + M145 extract 1.848
Table 3.2: The optical density of SCB reporter grown in liquid culture under various conditions. The
culture conditions were maintained identical in all other respects. The optical density measurement at
the end of the culture period showed that kanamycin resistance in the SCB reporter was successfully
induced in the liquid culture when S.coelicolor M145 extract was added.
Subsequently, the SCB reporter assay was conducted in a 96-well plate high through-
put liquid culture screening format. However, when scaled down to the 200 µL assay
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volume in the 96-well plates, the optical density measurement at the end of the incu-
bation showed that the SCB reporter failed to grow in the wells even in the absence of
kanamycin in the medium. Although other assay conditions were identical to flask cul-
tures, 96-well plates have limitations in aeration and mixing which presumably affected
the ability of the reporter strain to grow.
Chapter 4
Conclusions
Streptomyces is a genus of considerable interest since they are the most important
source of antibiotics for medical, veterinary and agricultural use [9]. Study of signal-
ing among Streptomyces has potential applications in various fields like drug discovery,
ecology and agriculture. The extent of signaling among Streptomyces in terms of fre-
quency and specificity, the identity of various types of signaling molecules, their roles in
inter-species and possibly inter-kingdom interactions through regulation of important
processes like antibiotic production is a growing field of study. Practical applications of
this field include the potential to harness signaling molecules to induce or up-regulate the
production of novel or important secondary metabolites like antibiotics or anti-cancer
compounds from Streptomyces. The largest class of signaling molecules that have been
identified from Streptomyces are GBLs. In this study, the development of two new
GBL reporters was undertaken and screening studies were conducted together with a
previously developed reporter to expand our knowledge of the GBL signaling process.
The induction of antibiotic production is the traditional approach used for detecting
GBL signaling molecules produced by Streptomyces, but this method has several draw-
backs. In co-cultures it can not give clear results if both strains are capable of producing
antibiotics, as is often the case with Streptomyces. It also does not provide information
about the potential chemical identity of the signaling molecule or the ligand specificity to
the receptor. Therefore, receptor based reporters are highly desirable and such a system
for detecting A-factor and VB type GBLs was attempted in this study. In conjunction
with the previously developed SCB reporter, these reporters serve as tools for studying
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GBL mediated signaling among Streptomyces. By screening Streptomyces extract li-
braries using the A-factor and SCB reporters in the kanamycin resistance bioassay, two
environmental isolates from diverse geographical locations with known antibiotic activ-
ity were identified to produce GBLs, most likely SCB type. The isolation, structural
elucidation and functional role determination of these potentially new GBL type sig-
naling compounds from the isolates will aid in expanding our knowledge of GBL based
signaling systems.
The results from the screening showed that the proper culture and extraction tech-
niques are key to the successful identification of GBL-like compounds from Streptomyces
using the reporters. The extracts prepared from three day cultures grown on solid
minimal medium consistently showed a higher likelihood for the presence of GBL-like
compounds. In this study, one out of seven environmental Streptomyces isolate cultures
extracted using this method induced the SCB reporter. This is similar to the results of
Hsiao et al. where identically prepared extracts from two out of nine known antibiotic
producing Streptomyces strains induced the SCB reporter. In contrast, only one out 37
extracts from the liquid culture extract library was able to induce the SCB reporter.
An attempt was made to modify the assay in order to circumvent the lengthy GBL
extraction process. This was done by testing live cultures of Streptomyces with the SCB
and A-factor reporters in the modified kanamycin resistance overlay bioassay. Multi-
ple time points were used in the assay to account for the temporal variability in the
GBL production and the chemical instability of GBLs in the medium. The relative
ease with which this assay could be performed enabled a large number of strains to
be screened with the GBL reporters at different growth stages in this study. Although
the initial results from the kanamycin resistance overlay bioassay were promising, per-
forming further control experiments showed that kanamycin resistance mechanisms are
widespread among soil Streptomyces and this caused interference with kanamycin resis-
tance reporter gene in the reporters. A high throughput liquid culture format for the
kanamycin resistance bioassay was also attempted. Though the initial large-scale liq-
uid culture study was successful, 96-well plate culture conditions were found to require
further optimization.
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Future Directions
Phylogenetic analysis of GBL synthases has shown that the A-factor synthase, AfsA,
shares the highest amino acid identity (66%) to the SCB synthase, ScbA [57]. However,
none of the extracts tested in this study, including two strains that induced the SCB re-
porter, activated the A-factor reporter. While this could be an indication that A-factor
type GBLs are less common than SCB type, it pointed to the necessity for a synthetic,
pure A-factor standard to measure its sensitivity and to positively confirm its ability to
bind to A-factor. A-factor was successfully synthesized after this study was concluded
and when tested with the A-factor reporter, it failed to elicit a positive response (un-
published data). The root cause for the inability of the reporter to detect the signaling
molecule successfully will need to be investigated and based on that necessary modifi-
cations have to be implemented in the A-factor reporter. New strategies to address the
instability of the VB reporter also need to be developed and its ability to bind to VB
molecules positively confirmed so that the VB reporter can be used in conjunction with
the A-factor and SCB reporters for studying VB-type GBLs in Streptomyces.
The clear logical extension of the screening study would be to understand the chem-
ical identity of molecules that induced the SCB reporter in the kanamycin resistance
bioassay. Larger scale culture extractions followed by techniques such as bioassay guided
fractionation using HPLC and structure determination using NMR may be employed
to identify the active GBL type compounds from the extract. Further cell culture stud-
ies and gene expression analysis are required for identifying the role of these GBLs in
inducing the antibiotic production or other behaviors in the producing species. Many
of the Streptomyces strains in the strain library which are known to have antibacterial
and anti-fungal activities, but did not induce the reporters in this screening study need
to be properly extracted and screened again with multiple reporters for the presence of
GBL type compounds.
The results of this study show that it is necessary for microbial cultures to be ex-
tracted in a specific extraction process for the GBLs to be detected by the reporters.
This could potentially impede the use of reporters in large-scale study of ecological
interactions among Streptomyces through GBL signaling. Other issues observed with
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this reporter system are the genetic instability of the Streptomyces chromosomal con-
structs, the sensitivity of kanamycin to media conditions and the interference caused
by kanamycin resistant Streptomyces sp. All these factors affect the robustness of the
reporters and point to the need to explore additional strategies for developing GBL
reporters. The substitution of the kanamycin resistance gene with other commonly
utilized reporter genes such as green fluorescent protein (GFP) might prove beneficial,
especially with regard to lowering the detection limit to enable testing of live cultures
as well as high throughput liquid culture assays. Even though using S.coelicolor as the
host strain for developing the reporters ensured that GBLs are properly transported into
the cell, using alternative strategies like lysing the cells prior to testing could potentially
enable other strains, like methylation deficient E.coli ET12567, to be used as host. An
E.coli based reporter might prove to be more genetically stable, easily adaptable to
high throughput 96-well plate formats and also shorten the assay length due to faster
growth.
These strategies need to be explored for developing stable and easy to use GBL
reporters that will function as valuable tools in furthering Streptomyces signaling re-
search.
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